Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  IntelGenx Technologies Corp.    IGX

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 8,25 M
EBIT 2016 2,53 M
Net income 2016 2,52 M
Debt 2016 -
Yield 2016 -
Sales 2017 17,2 M
EBIT 2017 11,7 M
Net income 2017 8,13 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 11,84
P/E ratio 2017 4,84
Capi. / Sales 2016 4,12x
Capi. / Sales 2017 1,98x
Capitalization 34,0 M
More Financials
Company
IntelGenx Technologies Corp. operates as a drug delivery company.It focuses on the development of novel, orally administered drug delivery products based on its proprietary oral drug delivery technologies.The company is a provider of product development services for the pharmaceutical industry,... 
Sector
Pharmaceuticals
Calendar
08/02Earnings Release
More about the company
Latest news on INTELGENX TECHNOLOGIES COR
05/12 INTELGENX TECHNOLOGIES : Reports Amendment of Stock Option Plan
05/11 INTELGENX TECHNOLOGIES CORP. : Submission of Matters to a Vote of Security Holde..
05/11 INTELGENX TECHNOLOGIES : reports 1Q loss
05/11 INTELGENX TECHNOLOGIES : posts loss of $746,000 in first quarter
05/10 INTELGENX TECHNOLOGIES : Reports First Quarter 2016 Financial Results
05/10 INTELGENX TECHNOLOGIES : Reports First Quarter 2016 Financial Results
05/10 INTELGENX TECHNOLOGIES : Reports First Quarter 2016 Financial Results
05/06 INTELGENX TECHNOLOGIES CORP. : Other Events (form 8-K)
More news
Sector news : Generic Pharmaceuticals
01:26p ROCHE : Lariam should be 'drug of last resort' for troops
12:31p ELI LILLY : Lilly Details Robust R&D Pipeline to Investment Community
12:28pDJGlaxoSmithKline Says Salford Lung Study Has Positive Results
More sector news : Generic Pharmaceuticals
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions